Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|November 29, 2007
Biochemical characterization of genetic mutations of GPR56 in patients with bilateral frontoparietal polymicrogyria (BFPP)Ning Ke, Hongwen Ma, Gundo Diedrich, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 7, 2011
Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic deliverySherine Abdelmawla, Songchuan Guo, Limin Zhang, et al.
Plos One|May 20, 2024
An NGS-based assay for accurate detection and quantification of immune gene expression in mouse tumor modelsJia Xue, Xiaobo Chen, Xiaoyu An, et al.
Journal of Visualized Experiments : Jove|May 17, 2021
Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived OrganoidsMarrit Putker, Rosemary Millen, René Overmeer, et al.
Biotechniques|May 22, 2004
One-week 96-well soft agar growth assay for cancer target validationNing Ke, Aaron Albers, Gisela Claassen, et al.
The Journal of Infectious Diseases|June 11, 2010
A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivoAnne Moscona, Matteo Porotto, Samantha Palmer, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|May 26, 2017
[Monocarboxylate transporter 1 enhances the sensitivity of breast cancer cells to 3-bromopyruvate in vitro]Qi-Xiang Li, Pei Zhang, Fang Liu, et al.
Scientific Reports|November 15, 2024
Preclinical pharmacology characterization of HX009, a novel PD1 x CD47 Bi-specific antibodyHang Ke, Tao Yang, Faming Zhang, et al.
Assay and Drug Development Technologies|September 27, 2005
A 96-well surrogate survival assay coupled with a special short interfering RNA vector for assessing cancer gene targets with enhanced signal/noise ratio and its utility in HTS for cancer therapeutic targetsDe-Hua Yu, Jon E Chatterton, Joshua R Bliesath, et al.
Plos One|December 17, 2008
Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapyDe-Hua Yu, James Macdonald, Guohong Liu, et al.
Pageof 5